Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Patricia Whitaker"'
Autor:
Mary Niu, Sarah Yukiko Asaki, Susan P. Etheridge, Zhining Ou, Jason T. Su, Angela P. Presson, Thomas A. Pilcher, Patricia Whitaker, Lindsey Gakenheimer-Smith, Michael D. Puchalski
Publikováno v:
Pacing Clin Electrophysiol
BACKGROUND Heart Rhythm Society guidelines outlining magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIEDs) excluded children and epicardial or abandoned leads due to theoretical risks of harm. Research inves
Publikováno v:
Pacing and Clinical Electrophysiology. 38:42-47
Background Pediatric and congenital heart disease (CHD) patients requiring permanent pacing present unique challenges, including need for long duration of implant, small size, and structural abnormalities. We report 6 years of experience with a novel
Autor:
G. L. Stiegler, Jaret R. Bogdan, R. W. Sebring, S. J. Penner, Julius S. Youngner, Robert E. Holland, Hugh G.G. Townsend, T. M. Chambers, D.P. Lunn, A. Cook, S. Hussey, Patricia Whitaker-Dowling, Lynn R. Tudor
Publikováno v:
Scopus-Elsevier
Flu Avert IN vaccine is a new, live attenuated virus vaccine for equine influenza. We tested this vaccine in vivo to ascertain 1) its safety and stability when subjected to serial horse to horse passage, 2) whether it spread spontaneously from horse
Autor:
Michael D. Puchalski, Patricia Whitaker, Elizabeth V. Saarel, L. LuAnn Minich, Aaron F. Pulver, T D O Jason Su, Susan P. Etheridge, David J. Bradley
Publikováno v:
Pacing and Clinical Electrophysiology. 32:450-456
Background: Magnetic resonance imaging (MRI) is a standard of care in evaluating many disease processes. Given concerns about device damage or movement, programming changes, lead heating, inappropriate pacing, and image artifact, MRI is contraindicat
Publikováno v:
Cancer Gene Therapy. 16:44-52
Vesicular stomatitis virus (VSV) is being developed for cancer therapy. We created a recombinant replicating VSV (rrVSV) that preferentially infected Her2/neu expressing breast cancer cells. We now used this rrVSV to treat macroscopic peritoneal tumo
Publikováno v:
Anticancer research. 35(9)
Cancer immune therapy is difficult partly because several classes of suppressor cells, including regulatory T-cells and macrophage-derived suppressor cells, inhibit the antitumor T-cell response. We used treatment studies of implanted tumors in mice
Publikováno v:
Journal of Virology. 80:8603-8612
Vesicular stomatitis virus (VSV) is being developed for cancer therapy. We created a recombinant replicating VSV (rrVSV) that preferentially infected Her2/neu-expressing breast cancer cells. This rrVSV did not express the native VSV-G glycoprotein (g
Publikováno v:
Virology. 316:337-347
Vesicular stomatitis virus (VSV) is a candidate for development for cancer therapy. It is an oncolytic virus that is safe in humans. Recombinant virus can be made directly from plasmid components. We attempted to create a virus that targeted specific
Autor:
Yuh-Fun Maa, Dexiang Chen, Patricia Whitaker-Dowling, Kensil Cr, Julius S. Youngner, Anita M. Trichel, Ryan L. Endres, Lendon G. Payne
Publikováno v:
Vaccine. 21:2830-2836
Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure simi
Publikováno v:
International Congress Series. 1219:961-964
Background: Equine-2 (H3N8) influenza is the most frequent cause of infectious upper respiratory disease in horses in the USA. Conventional inactivated-virus vaccines have been largely ineffective for prevention of this disease, even following repeat